Valuation: ZIM Laboratories Limited

Market Cap 6.69B 69.41M 60.84M 56.24M 51.72M 97.59M 99.16M 672M 264M 3.28B 261M 255M 11.28B P/E 2025
32.1x
P/E 2026 50.3x
Enterprise Value 7.56B 78.36M 68.69M 63.49M 58.39M 110M 112M 759M 298M 3.7B 294M 288M 12.74B EV / Sales 2025
1.34x
EV / Sales 2026 1.09x
Free-Float
28.79%
Yield 2025 *
-
Yield 2026 -
1 day-0.36%
1 week+9.89%
Current month+0.56%
1 month+4.65%
3 months+56.80%
6 months+59.48%
Current year+73.88%
1 week 118.3
Extreme 118.3
125.5
1 month 111.5
Extreme 111.5
133.95
Current year 59.72
Extreme 59.72
133.95
1 year 59.72
Extreme 59.72
133.95
3 years 59.72
Extreme 59.72
151.75
5 years 36.37
Extreme 36.3667
151.75
10 years 14
Extreme 14
151.75
Manager TitleAgeSince
Chief Executive Officer - 2001-12-31
Director of Finance/CFO - 2019-03-31
Director of Finance/CFO - 1990-12-31
Director TitleAgeSince
Chairman - 1989-12-31
Director/Board Member - 1990-12-31
Director/Board Member - 2012-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%+9.89%+5.13%+2.42% 69.76M
+1.23%+1.08%+15.52%+80.84% 48.15B
-0.23%-1.65%+67.15%+109.36% 35.59B
+1.61%+0.15%-2.75%+39.18% 11.9B
+0.46%-0.16%+17.85%+89.14% 11.85B
+0.93%+2.87%+34.92%+137.61% 9.31B
+3.37%-0.10%+51.64%-4.77% 7.02B
-0.42%+0.25%+16.05%+34.73% 6.91B
-.--%+0.14% - - 6.79B
+0.18%-1.90%+0.63%+211.00% 6.55B
Average +0.68%+0.48%+22.91%+77.72% 14.41B
Weighted average by Cap. +0.74%-0.67%+29.99%+88.66%

Financials

2025 2026
Net sales 3.79B 39.32M 34.46M 31.85M 29.3M 55.28M 56.16M 381M 149M 1.86B 148M 144M 6.39B 3.74B 38.83M 34.03M 31.46M 28.93M 54.59M 55.46M 376M 147M 1.83B 146M 143M 6.31B
Net income 122M 1.26M 1.11M 1.02M 940K 1.77M 1.8M 12.22M 4.79M 59.52M 4.74M 4.63M 205M 58.38M 605K 531K 491K 451K 851K 865K 5.87M 2.3M 28.57M 2.27M 2.22M 98.42M
Net Debt 1.16B 12M 10.52M 9.73M 8.95M 16.88M 17.15M 116M 45.59M 566M 45.08M 44.09M 1.95B 863M 8.95M 7.84M 7.25M 6.67M 12.58M 12.79M 86.71M 33.99M 422M 33.61M 32.87M 1.45B
Logo ZIM Laboratories Limited
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Employees
632
Date Price Change Volume
26-07-20 125.00 -0.36% 2,296
26-07-17 ₹125.45 +1.95% 8,530
26-07-16 ₹123.05 +1.99% 3,069
26-07-15 ₹120.65 +1.99% 5,681
26-07-14 ₹118.30 +1.98% 2,646
  1. Stock Market
  2. Stocks
  3. ZIMLAB Stock